abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

Diese Seite ist nicht auf Deutsch verfügbar und wird angezeigt auf English

Unternehmensantwort

16 Apr 2018

Autor:
Novartis

Response by Novartis

At Novartis, corporate responsibility (CR) is central to how we run our business. Our CR strategy supports our company mission to discover new ways to improve and extend people’s lives and our vision to be a trusted leader in changing the practice of medicine. We focus our CR work in two key areas: expanding access to healthcare and doing business responsibly. 

To achieve our mission, we have a responsibility to use our expertise and skills to address the needs of underserved populations. We work to improve the affordability and availability of our medicines by pioneering sustainable and scalable access models. And we seek effective partnerships to help deliver treatments and quality care to as many people as possible. Read more about our access-to-healthcare programs on our website...

As a responsible company, we are committed to conducting our business in a manner that respects the rights and dignity of all people. Our full Modern Slavery Statement is available on our website. We are also fully committed to a cleaner environment for the benefit of our patients, our investors and our communities. More details on our approach to environmental sustainability are available on our website...